A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen-Receptor Positive Primary Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Breast Carcinoma|Breast Tumors
Interventions: DRUG: Letrozole|DRUG: palbociclib
Sponsor: NSABP Foundation Inc
Collaborators: Pfizer|Royal Marsden NHS Foundation Trust|Institute of Cancer Research, United Kingdom